Sphera Funds Management Ltd. Sarepta Therapeutics, Inc. Transaction History
Sphera Funds Management Ltd.
- $380 Million
- Q1 2025
A detailed history of Sphera Funds Management Ltd. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 157,931 shares of SRPT stock, worth $5.99 Million. This represents 2.65% of its overall portfolio holdings.
Number of Shares
157,931
Previous 98,921
59.65%
Holding current value
$5.99 Million
Previous $12 Million
16.2%
% of portfolio
2.65%
Previous 2.48%
Shares
22 transactions
Others Institutions Holding SRPT
# of Institutions
506Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$391 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$343 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$342 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$154 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$128 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $3.32B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...